E-LIB Suche - Ergebnisse für: Cherry, Mohamad

1

CT-045 Primary Results From OUTREACH: A Phase II Study of L..:

Linhares, Yuliya ; Freytes, Cesar ; Cherry, Mohamad...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S514-S515 , 2023

Link: https://doi.org/10.1016/..

2

Gray zone lymphoma: A case report and comprehensive review ..:

Uczkowski, Dariusz ; Ashraf, Hamza ; Cherry, Mohamad.
Leukemia Research Reports. 19 (2023) - p. 100372 , 2023

Link: https://doi.org/10.1016/..

3

POSTER: CT-045 Primary Results From OUTREACH: A Phase II St..:

Linhares, Yuliya ; Freytes, Cesar ; Cherry, Mohamad...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S233 , 2023

Link: https://doi.org/10.1016/..

4

Poster: AML-256 A Phase 1 Study of Gilteritinib in Combinat..:

Pratz, Keith W. ; Cherry, Mohamad ; Podoltsev, Nikolai A....
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S126 , 2022

Link: https://doi.org/10.1016/..

5

AML-256 A Phase 1 Study of Gilteritinib in Combination With..:

Pratz, Keith W. ; Cherry, Mohamad ; Podoltsev, Nikolai A....
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S230 , 2022

Link: https://doi.org/10.1016/..

6

Outcomes of Treatment with the Chimeric Antigen Receptor (C..:

Godwin, John ; Freytes, Cesar O. ; Maris, Michael...
Transplantation and Cellular Therapy. 27 (2021) 3 - p. S203-S204 , 2021

Link: https://doi.org/10.1016/..

7

Database-Guided Analysis for Immunophenotypic Diagnosis and..:

Aanei, Carmen-Mariana ; Veyrat-Masson, Richard ; Selicean, Cristina...
Frontiers in Oncology. 11 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

8

Natural Killer Cell Subpopulations and Inhibitory Receptor ..:

Cianga, Vlad Andrei ; Campos Catafal, Lydia ; Cianga, Petru...
Frontiers in Immunology. 12 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

9

Point-of-Care Assays Could Be Useful for Therapeutic Drug M..:

Cherry, Mohamad ; Dutzer, Dominique ; Nasser, Yara...
Journal of Clinical Medicine. 9 (2020) 9 - p. 2739 , 2020

Link: https://doi.org/10.3390/..

10

Combination trial of duvelisib (IPI‐145) with rituximab or ..:

Flinn, Ian W. ; Cherry, Mohamad A. ; Maris, Michael B....
American Journal of Hematology. 94 (2019) 12 - p. 1325-1334 , 2019

Link: https://doi.org/10.1002/..

11

Characterization of Duvelisib in Patients with Refractory M..:

Jacobsen, Eric ; Ďuraš, Juraj ; Ardeshna, Kirit...
Clinical Lymphoma Myeloma and Leukemia. 19 (2019) - p. S312-S313 , 2019

Link: https://doi.org/10.1016/..

12

Granulocytic sarcoma and mediastinal germ cell tumor: A com..:

Mukherjee, Sarbajit ; Ibrahimi, Sami ; Scordino, Teresa.
Hematology/Oncology and Stem Cell Therapy. 12 (2019) 4 - p. 228-229 , 2019

Link: https://doi.org/10.1016/..

13

Sustained response to lenalidomide for early relapsed margi..:

Ibrahimi, Sami ; Vidal, Gabriel ; Mukherjee, Sarbajit...
Blood Cells, Molecules, and Diseases. 71 (2018) - p. 53-54 , 2018

Link: https://doi.org/10.1016/..

14

Extranodal Marginal Zone Lymphoma of the Central Nervous Sy..:

Ayanambakkam, Adanma ; Ibrahimi, Sami ; Bilal, Khalid.
Clinical Lymphoma Myeloma and Leukemia. 18 (2018) 1 - p. 34-37.e8 , 2018

Link: https://doi.org/10.1016/..

15

Efficacy of High-Dose Therapy and Autologous Hematopoietic ..:

Kharfan-Dabaja, Mohamed A. ; Raj, Renju ; Nikolaenko, Liana...
Biology of Blood and Marrow Transplantation. 24 (2018) 3 - p. 486-493 , 2018

Link: https://doi.org/10.1016/..